Literature DB >> 21532115

[Diabetes Mellitus and bone metabolism].

Ryo Okazaki1.   

Abstract

Deranged bone metabolism including osteoporosis is now clinically recognized as one of the diabetic complications. Diabetes could affect bone through multiple mechanisms, insulin deficiency, insulin resistance, hyperglycemia, atherosclerosis, etc. However, the exact mechanisms by which bone derangement is brought about in diabetes are yet unknown. In type 2 diabetes, fracture risk is increased despite high bone mineral density (BMD) through deteriorated "bone quality" , of which assessment is clinically difficult. Thus, it would be important for physicians to recognize diabetes as a fracture risk, and to assess each patient's fracture risk using available tools i.e. BMD, metabolic bone markers, etc. Intense treatment for osteoporosis is warranted in diabetics who have other established fracture risks such as those with prevalent fractures or postmenopausal state.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21532115     DOI: CliCa1105669675

Source DB:  PubMed          Journal:  Clin Calcium        ISSN: 0917-5857


  3 in total

1.  Nigella sativa: A Potential Antiosteoporotic Agent.

Authors:  Ahmad Nazrun Shuid; Norazlina Mohamed; Isa Naina Mohamed; Faizah Othman; Farihah Suhaimi; Elvy Suhana Mohd Ramli; Norliza Muhammad; Ima Nirwana Soelaiman
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-03       Impact factor: 2.629

2.  Clinical investigation of patients with jaw deformity with comorbidities.

Authors:  Kiyohiro Kasahara; Teruhide Hoshino; Kei Sugiura; Yuki Tanimoto; Masahide Koyachi; Masae Yamamoto; Keisuke Sugahara; Masayuki Takano; Akira Katakura
Journal:  Maxillofac Plast Reconstr Surg       Date:  2022-04-06

3.  The effects of natural nano-sized clinoptilolite and Nigella sativa supplementation on serum bone markers in diabetic rats.

Authors:  Yalda Salari Lak; Sirous Khorram; Mehran Mesgari Abbasi; Mohammad Asghari-Jafarabadi; Ali Tarighat-Esfanjani; Elahe Bazri; Hossein Omidi
Journal:  Bioimpacts       Date:  2019-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.